Back to News
Market Impact: 0.25

Graphene Investments Liquidates Entire $2.95 Million Bath & Body Works Stake Amid Turnaround Challenges

BBWIGOOGLAAPLNVDAMSFTAVGONDAQ
Consumer Demand & RetailCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookManagement & GovernanceInvestor Sentiment & PositioningAnalyst InsightsMarket Technicals & Flows
Graphene Investments Liquidates Entire $2.95 Million Bath & Body Works Stake Amid Turnaround Challenges

Graphene Investments SAS fully liquidated its Bath & Body Works (BBWI) stake in Q4, selling 114,700 shares for an estimated $2.95 million and reducing the position from roughly 1.9% of the fund's AUM to zero. BBWI shares traded at $21.45 as of January 26, 2026, down ~39.5% over the past year; company TTM revenue is $7.35 billion with net income of $699 million and a 3.74% dividend yield. The exit follows weak results—Q3 revenue of $1.59 billion (-1% YoY) and adjusted EPS of $0.35 that missed expectations—plus a slashed full‑year outlook and a $250 million cost‑cutting plan from new CEO Daniel Heaf, prompting analysts to remain cautious with a hold consensus. The trade signals a decisive loss of confidence from a reporting institutional investor and may reinforce negative sentiment among value and turnaround investors.

Analysis

Market structure: Graphene's full exit from BBWI is a signal of institutional de-risking in specialty retail — direct losers are BBWI and other promotion-driven apparel/home-fragrance peers (expected near‑term margin contraction of ~200–400bp). Winners are high‑quality tech and large-cap dividend names (GOOGL, AAPL, NVDA, MSFT, AVGO) that benefit from reallocated passive/active flows and lower perceived execution risk; expect 4–8 week rotation into these liquid mega‑caps if retail earnings stay weak. Risk assessment: Near term (days–weeks) the main risk is a liquidity/volatility spike around earnings and guidance updates (repeat 25% single‑day drops are plausible). Over months–years, tail risks include a dividend cut (yield 3.74%, cut would indicate deeper cash flow stress), a failed execution of the $250M cost program, or inventory write‑downs; hidden dependencies include franchise/licensing revenue lags and promotional elasticity that could permanently erode pricing power. Trade implications: Direct tactical plays: capitalize on elevated implied volatility in BBWI options (timeframe 1–3 months) with defined‑risk bearish spreads, while funding a small contrarian LEAP for multi‑year optional upside; rotate 1–3% AUM from discretionary into GOOGL/AAPL/NVDA for quality exposure. Use pair trades (short BBWI, long NVDA or GOOGL) to exploit relative strength — hedge on notional or beta to limit sector shocks. Contrarian angles: The market may be overpricing permanent brand damage — BBWI still produces healthy net income/FCF and a 3.7% yield; Graphene's $2.95M liquidation is immaterial to market cap and likely thesis‑specific, not industry‑ending. If cost cuts deliver >$150M EBITDA improvement within 12–18 months or inventory normalizes, a 30–60% bounce from cycle lows is possible; monitor insider buys, margin inflection, and guidance revisions as high‑probability reversal catalysts.